Roche Holding Ltd. (ROG) Given a CHF 325 Price Target at Goldman Sachs Group, Inc. (The)

Goldman Sachs Group, Inc. (The) set a CHF 325 price target on Roche Holding Ltd. (VTX:ROG) in a research report sent to investors on Monday. The firm currently has a buy rating on the healthcare company’s stock.

ROG has been the topic of several other research reports. Deutsche Bank AG set a CHF 273 price target on shares of Roche Holding and gave the company a buy rating in a report on Tuesday, June 6th. Barclays PLC set a CHF 320 price target on shares of Roche Holding and gave the company a buy rating in a report on Saturday, May 20th. Citigroup Inc. reiterated a buy rating on shares of Roche Holding in a report on Wednesday, July 5th. Kepler Capital Markets set a CHF 231 price target on shares of Roche Holding and gave the company a neutral rating in a report on Tuesday, June 6th. Finally, Sanford C. Bernstein set a CHF 284 price target on shares of Roche Holding and gave the company a buy rating in a report on Thursday, July 27th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the stock. The company currently has a consensus rating of Hold and a consensus price target of CHF 268.20.

Roche Holding (VTX ROG) opened at 242.40 on Monday. The firm has a market cap of CHK 206.83 billion and a P/E ratio of 21.52. The company’s 50 day moving average is CHK 243.48 and its 200-day moving average is CHK 252.56. Roche Holding has a 52-week low of CHK 218.30 and a 52-week high of CHK 273.00.

ILLEGAL ACTIVITY WARNING: “Roche Holding Ltd. (ROG) Given a CHF 325 Price Target at Goldman Sachs Group, Inc. (The)” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://sportsperspectives.com/2017/09/12/roche-holding-ltd-rog-given-a-chf-325-price-target-at-goldman-sachs-group-inc-the.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply